Form 4 for HCA HCA Healthcare
Accepted 2026-02-10 00:00:00 ET · period of report 2026-02-06 · accession 0001140361-26-004682 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-10 | 2026-02-06 | HCA | HERCULES HOLDING II | 10% | J - Other | $0.00 | -36.63M | 32.28M | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2026-02-06 | J | D | 36,629,188 | $0.00 | 32,282,889 | D | — | — | (F1) This transaction represents a distribution for no consideration and on a pro rata basis by the Reporting Person of 36,629,188 shares of Common Stock, par value $0.01 per share, of HCA Healthcare, Inc. to Frisco Holding II, which shares had previously been indirectly beneficially owned through the Reporting Person. (F2) The Reporting Person is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. |